Table 1.
Mean age Years (range) |
Male | Other complicationb | HBV positive | Treatment time > 1 year | Treatment program | |
---|---|---|---|---|---|---|
Patients (n = 40) | 49.7 (31–75) | 28 (70%a) | 12 (40%) | 22 (55%) | 26 (52%) | TACEc |
Control (n = 20) | 41 (28–55) | 12 (60%) | 0 (0%) | 0 (0%) |
aThe percentage of patients with the characteristic
bOther Complication include liver cirrhosis
cThe treatment programs: TACE: Transarterial chemoembolization